EQRx is a biotechnology company focused on developing important new medicines and offering them at lower prices through strategic partnerships with stakeholders from across the healthcare system and cutting-edge science and technology.

Register for Details

For more details on financing and valuation for EQRx, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is EQRx's ticker symbol?


What is EQRx's stock price?

1.71 as of 5/26/23

EQRx Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
1/11/2021 Series B $570MM raised $XXX.XX $XXX.XX
1/13/2020 Series A $243.88MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Learn more about EQRx

Forge green plus iconForge green minus icon

What is EQRx funding to date?

EQRx has raised $813.88MM with the following series:
$243.88MM raised for Series A,$570MM raised for Series B.
Forge green plus iconForge green minus icon

When was EQRx founded?

EQRx was founded in 2019.